For citations:
Polyakov A.S., Noskov Y.A., Tyrenko V.V., Lapshova A.S., Kovalev A.V. NEW APPROACHES TO THERAPY OF CLASSICAL PH-NEGATIVE MYELOPROLIFERATIVE DISEASES: THE EXPERIENCE OF EARLY THERAPY WITH CEPEGINTERFERON ALPHA-2B. Oncohematology. 2018;13(1):29-44. (In Russ.) https://doi.org/10.17650/1818-8346-2018-13-1-29-44
Email this article 